Market Trends Cytokinetics started at buy by Stifel, aficamten highlightedBy admin8996erT0allJanuary 22, 2025 peterschreiber.mediaStifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock…
Market Trends An Nvidia derivative on the move, a bank stock just getting startedBy admin8996erT0allJanuary 16, 2025 (This is a wrap-up of the key money moving discussions on CNBC’s “Worldwide Exchange” exclusive for PRO subscribers. Worldwide Exchange…
Trading Platforms US stocks move higher as the day gets startedBy admin8996erT0allJanuary 14, 2025 The NASDAQ index has been down for four consecutive days, but is leading the way higher with a gain of…
Cryptocurrency Is There a US Dollar Crisis at The Fed: Bitcoin in 2025 is Just Getting StartedBy admin8996erT0allJanuary 13, 2025 The crypto market and US dollar have been anything but stable since Donald Trump took the White House. His pro-crypto…
Market Trends These stocks had a big 2024 and analysts think the party is just getting startedBy admin8996erT0allDecember 31, 2024 Some stocks leading this year’s bull rally could be destined for another year of outperformance. Except for a few notable…
